Marinomed Biotech AG: Half-yearly financial report according to article 125 BörseG

Korneuburg (pta012/17.08.2023/07:45 UTC+2) - Marinomed Biotech AG announces that the following financial reports shall be disclosed:

Report: Half year report 2023
Web publication: https://www.marinomed.com/en/investors-esg/financial-publications
Publication date: 17.08.2023

Short description: Half-yearly financial report 2023

(end)

Emitter:	Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria
Contact Person:	Pascal Schmidt, CFO
Phone:	+43 2262 90300
E-Mail:	pascal.schmidt@marinomed.com
Website:	www.marinomed.com
ISIN(s):	ATMARINOMED6 (Share)
Stock Exchange(s):	Vienna Stock Exchange (Official Trade)